NCRI 2019

The 2019 National Cancer Research Institute (NCRI) Annual Cancer Conference, took place on 3-5 November in Glasgow, UK. Watch our expert interviews from the largest cancer research conference in the UK.

Targeted screening and risk stratification of prostate cancer – updates from the IMPACT study 2:43
Targeted screening and risk stratification of prostate cancer – updates from the IMPACT study
Rosalind Eeles
Producing patient-specific tumor-reactive T-cells 3:05
Producing patient-specific tumor-reactive T-cells
Chiara Cattaneo
Is age a barrier for chemotherapy? 5:04
Is age a barrier for chemotherapy?
Nicolo Battisti
Radiation on tumor antigenicity and adjuvanticity 3:56
Radiation on tumor antigenicity and adjuvanticity
Sandra Demaria
Challenges with chemotherapy in older patients 1:56
Challenges with chemotherapy in older patients
Nicolo Battisti
The UK approach to proton beam therapy clinical trials 4:30
The UK approach to proton beam therapy clinical trials
David Sebag-Montefiore
Other factors to consider with radiation effects on tumor antigenicity and adjuvanticity 2:15
Other factors to consider with radiation effects on tumor antigenicity and adjuvanticity
Sandra Demaria
Managing patients’ fear of cancer progression 3:34
Managing patients’ fear of cancer progression
Phyllis Butow
Enthusiasm bias with novel robotic technology for surgery 2:53
Enthusiasm bias with novel robotic technology for surgery
Peter McCulloch
Precision medicine in gastrointestinal cancers: promise and pitfalls 3:09
Precision medicine in gastrointestinal cancers: promise and pitfalls
Russell Petty
Epigenetics and epitranscriptomics: from knowledge to applications 3:21
Epigenetics and epitranscriptomics: from knowledge to applications
Manel Esteller
The future of proton beam therapy: assistance from European clinical trials 1:37
The future of proton beam therapy: assistance from European clinical trials
Cai Grau
Robotic technology: hype or game changers? 2:36
Robotic technology: hype or game changers?
Peter McCulloch
Colorectal cancer subtyping using a histology based approach 4:31
Colorectal cancer subtyping using a histology based approach
Joanne Edwards
HER-2 conversion: a phenomenon in trastuzumab resistance 2:13
HER-2 conversion: a phenomenon in trastuzumab resistance
Russell Petty
Clinical studies of obesity in oncogenesis and treatment response 3:38
Clinical studies of obesity in oncogenesis and treatment response
Stephen Hursting
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals